More NewsRead More
BioTime Appoints Angus C. Russell to Board of Directors
December 15, 2014
BioTime to Host Investor and Analyst Day on December 15, 2014
December 12, 2014
BioTime to Present at the LD Micro VII Conference
December 03, 2014
BioTime Reports Third Quarter Results and Recent Progress
November 10, 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia™ in Europe
November 04, 2014
BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa Trial of Embryonic Stem Cell-Derived OpRegen® for the Treatment of the Dry Form of Age-Related Macular D
November 03, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here